Allergan Aesthetics takes a 360°approach to non-surgical aesthetic treatments to improve patient outcomes with expert-led medical education symposium at IMCAS 2023
Allergan Aesthetics, part of AbbVie (NYSE: ABBV), launched its 'Discover your 360°' initiative at the 24th IMCAS World Congress in Paris. This experience focuses on meeting aesthetic practitioners' and patients' evolving needs through innovative products and education. Key themes include Gender Inclusive Beauty and The End of Aging, discussed in various symposiums. Dr. Arthur Swift leads the opening symposium on Jan 28, with sessions featuring world-renowned experts. The event aims to enhance patient outcomes and supports practitioners with valuable insights. Allergan's commitment to aesthetics is reflected in its extensive product portfolio.
- Launch of 'Discover your 360°' initiative aimed at enhancing aesthetics practices.
- Participation in the IMCAS World Congress to support practitioner education.
- Key industry themes discussed, indicating a forward-thinking approach.
- Collaboration with renowned experts adds credibility and value to offerings.
- None.
As part of a 360° offering, Allergan Aesthetics aims to fulfil practitioners' business goals as well as continue to provide world class medical education. In its recently launched global trends report, Future of Aesthetics, which explores how the Aesthetics industry is being shaped by social and cultural shifts, Allergan Aesthetics anticipates how industry behaviours will evolve and thus meet the needs of practitioners and patients. Themes such as Gender Inclusive Beauty, the New Masculine and The End of Aging will be discussed at the Allergan Medical Institute® (AMI) hosted symposium, interactive booth, and during the company's participation in three industry panels.
World-renowned plastic and cosmetic surgeon Dr.
Specialist plastic surgeon Dr.
At the Allergan Aesthetics booth – [N227, Level 2, Palais des Congrès
Commenting on the congress,
As well as the symposium and booth activity, Allergan Aesthetics will also take part in three exciting expert panels: one on emerging toxins, a filler panel event, and the economic tribune on Friday, 27 January
Ends
Notes to Editors:
About Allergan Aesthetics
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch. For more information, visit www.AllerganAesthetics.com
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on
1 Ipsos Global Survey,
SOURCE AbbVie
FAQ
What is Allergan Aesthetics' 'Discover your 360°' initiative?
When was the 'Discover your 360°' initiative launched?
What key themes are explored in Allergan Aesthetics' offerings?
Who is leading the symposium at IMCAS on January 28, 2023?